- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
HLB Therapeutics Co Ltd (115450)
Track today's live HLB Therapeutics (115450) share price, performance and key data on this page with our current KOSDAQ:115450 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the HLB Therapeutics share price on the KOSDAQ exchange. Use the dropdown to switch exchange for the 115450 share price, head to our technical summary section, which provides analysis on HLB Therapeutics share price buy/sell indicators using real-time data (or discuss the HLB Therapeutics (115450) stock price today with other investors in the HLB Therapeutics KQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KQ:115450 share price (ISIN: KR7115450009) to enhance your trading decisions with our free investment tools and resources.
What Is the HLB Therapeutics Co Ltd Share Price Today?
The HLB Therapeutics share price today is 2,105.
What Is the Stock Symbol for HLB Therapeutics Co Ltd
The stock symbol (or 'ticker') for HLB Therapeutics Co Ltd is "115450."
What Stock Exchange Does HLB Therapeutics Co Ltd Trade On?
HLB Therapeutics Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is HLB Therapeutics Co Ltd a Good Stock to Buy?
Determining whether HLB Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current KQ:115450 share price (ISIN: KR7115450009) to enhance your trading decisions with our free investment tools and resources.
What Is the HLB Therapeutics Co Ltd Share Price Today?
The HLB Therapeutics share price today is 2,105.
What Is the Stock Symbol for HLB Therapeutics Co Ltd
The stock symbol (or 'ticker') for HLB Therapeutics Co Ltd is "115450."
What Stock Exchange Does HLB Therapeutics Co Ltd Trade On?
HLB Therapeutics Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is HLB Therapeutics Co Ltd a Good Stock to Buy?
Determining whether HLB Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
KOSDAQ
Currency in KRW
2,105
-150(-6.65%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,075
2,235
52 wk Range
1,342
4,160
115450 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,0752,235
52 wk Range
1,3424,160
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
115450 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
15/05/2026
EPS / Forecast
-49.00 / --
Revenue / Forecast
13.05B / --
Compare 115450 to Peers and Sector
Metrics to compare | 115450 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship115450PeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.8x | −14.7x | −0.3x | |
PEG Ratio | −0.34 | −0.16 | 0.00 | |
Price/Book | 1.4x | 1.8x | 2.6x | |
Price / LTM Sales | 3.0x | 7.5x | 3.1x | |
Upside (Analyst Target) | - | 50.8% | 47.6% | |
Fair Value Upside | Unlock | 13.2% | 5.6% | Unlock |
HLB Therapeutics Co.,Ltd., a biotech company, develops pharmaceutical products in South Korea and internationally. It is developing GBT-201 using Thymosin beta for the treatment of ophthalmic diseases, such as dry eye syndrome and neurotrophic keratopathy; and OKN-007 for the treatment of glioblastoma brain tumor. It is also involved in the wholesale of vaccines, as well as manufactures electrical and electronic components, such as motors, pumps, and transformers. The company was formerly known as G-treeBNT Co., Ltd. and changed its name to HLB Therapeutics Co.,Ltd. in December 2021. HLB Therapeutics Co.,Ltd. was founded in 2000 and is headquartered in Seongnam-si, South Korea.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the HLB Therapeutics (KOSDAQ: 115450) Share Price Today?
The HLB Therapeutics stock price today is 2,105 KRW.
What Stock Exchange Does HLB Therapeutics (115450) Trade On?
HLB Therapeutics is listed and trades on the KOSDAQ.
What Is the Ticker (Stock Symbol) for HLB Therapeutics?
The stock symbol (also called a 'ticker') for HLB Therapeutics is "115450."
What Is the Current HLB Therapeutics Market Capitalisation?
As of today, HLB Therapeutics (KOSDAQ: 115450) market cap is 194.86B KRW.
What Is HLB Therapeutics's (115450) Earnings Per Share (TTM)?
The HLB Therapeutics EPS is currently -103 (Trailing Twelve Months).
Is 115450 a Buy or Sell From a Technical Analyst Perspective?
Based on today's HLB Therapeutics moving averages and other technical indicators, the daily buy/sell signal for 115450 stock is Neutral.
How Many Times Has HLB Therapeutics Stock Split?
HLB Therapeutics has split 6 times. (See the 115450 stock split history page for full effective split date and price information.)
How Many Employees Does HLB Therapeutics Have?
HLB Therapeutics has 49 employees, based on their latest Companies House report.
What is the current trading status of HLB Therapeutics (KOSDAQ: 115450)?
As of 22/08/2026, HLB Therapeutics (115450) is trading at a share price of 2,105 KRW, with a previous close of 2,255 KRW. The stock has fluctuated within a day range of 2,075 KRW to 2,235 KRW, while its 52-week range spans from 1,342 KRW to 4,160 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.